Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28451 - 28475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	HAPLN1	1404	downregulated	Cytarabine results in decreased expression of HAPLN1 mRNA	5q14.3	A21886
Cytarabine	Approved Investigational	HAS2	3037	downregulated	Cytarabine results in decreased expression of HAS2 mRNA	8q24.13	A21886
Cytarabine	Approved Investigational	HCFC1R1	54985	downregulated	Cytarabine results in decreased expression of HCFC1R1 mRNA	16p13.3	A21886
Cytarabine	Approved Investigational	HES5	388585	upregulated	Cytarabine results in increased expression of HES5 mRNA	1p36.32	A21886
Cytarabine	Approved Investigational	HIST1H1C	3006	downregulated	Cytarabine results in decreased expression of HIST1H1C mRNA	6p22.2	A21886
Cytarabine	Approved Investigational	HIST1H4C	8364	downregulated	Cytarabine results in decreased expression of HIST1H4C mRNA	6p22.2	A20985
Cytarabine	Approved Investigational	HLA-DRB5	3127	downregulated	Cytarabine results in decreased expression of HLA-DRB5 mRNA	6p21.32	A21886
Cytarabine	Approved Investigational	HMGCS2	3158	downregulated	Cytarabine results in decreased expression of HMGCS2 mRNA	1p12	A21886
Cytarabine	Approved Investigational	HNRNPA3	220988	downregulated	Cytarabine results in decreased expression of HNRNPA3 mRNA	2q31.2	A21886
Cytarabine	Approved Investigational	HOXA2	3199	upregulated	Cytarabine results in increased expression of HOXA2 mRNA	7p15.2	A21886
Cytarabine	Approved Investigational	HOXA5	3202	upregulated	Cytarabine results in increased expression of HOXA5 mRNA	7p15.2	A21886
Cytarabine	Approved Investigational	HOXB4	3214	downregulated	Cytarabine results in decreased expression of HOXB4 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	HOXB6	3216	downregulated	Cytarabine results in decreased expression of HOXB6 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	HOXB8	3218	downregulated	Cytarabine results in decreased expression of HOXB8 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	HOXB-AS3	404266	downregulated	Cytarabine results in decreased expression of HOXB-AS3 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	HOXC6	3223	downregulated	Cytarabine results in decreased expression of HOXC6 mRNA	12q13.13	A21886
Cytarabine	Approved Investigational	HOXC8	3224	downregulated	Cytarabine results in decreased expression of HOXC8 mRNA	12q13.13	A21886
Cytarabine	Approved Investigational	HS3ST1	9957	downregulated	Cytarabine results in decreased expression of HS3ST1 mRNA	4p15.33	A21886
Cytarabine	Approved Investigational	HSPA6	3310	upregulated	Cytarabine results in increased expression of HSPA6 mRNA	1q23.3	A20985
Cytarabine	Approved Investigational	HTRA1	5654	downregulated	Cytarabine results in decreased expression of HTRA1 mRNA	10q26.13	A21886
Cytarabine	Approved Investigational	IFIT1	3434	downregulated	Cytarabine results in decreased expression of IFIT1 mRNA	10q23.31	A21886
Cytarabine	Approved Investigational	IGFBP3	3486	downregulated	Cytarabine results in decreased expression of IGFBP3 mRNA	7p12.3	A21886
Cytarabine	Approved Investigational	IGFBP5	3488	downregulated	Cytarabine results in decreased expression of IGFBP5 mRNA	2q35	A21886
Cytarabine	Approved Investigational	IMPAD1	54928	downregulated	Cytarabine results in decreased expression of IMPAD1 mRNA	8q12.1	A21886
Cytarabine	Approved Investigational	INA	9118	upregulated	Cytarabine results in increased expression of INA mRNA	10q24.33	A21886

Displaying entries 28451 - 28475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability